Latest Articles
Oriva Therapeutics appoints Dr Agnès Arbat as CEO to advance clinical-stage women’s health pipeline - GlobeNewswire
Oriva Therapeutics appoints Dr Agnès Arbat as CEO to advance clinical-stage women’s health pipeline GlobeNewswire
Published: June 11, 2026, 7:30 a.m.
p16 Beyond Senescence: Cancer Biology Lessons Applied to Endometriosis.
Endometriosis is an estrogen-dependent disease characterized by chronic inflammation and fibrosis and is a major cause of pelvic pain and infertility. Recent studies have reported dysregulated expression of p16INK4a, a …
Published: June 11, 2026, midnight
Surgical Treatment Experience of Intestinal Endometriosis.
Retrospective descriptive cohort.
Published: June 1, 2026, midnight
Acrivon Therapeutics’ SWOT analysis: stock shows promise in cancer pipeline - Investing.com UK
Acrivon Therapeutics’ SWOT analysis: stock shows promise in cancer pipeline Investing.com UK
Published: May 21, 2026, 8:34 p.m.
Acrivon Therapeutics’ SWOT analysis: stock shows promise in cancer pipeline - Investing.com
Acrivon Therapeutics’ SWOT analysis: stock shows promise in cancer pipeline Investing.com
Published: May 21, 2026, 2:57 p.m.
Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - BioSpace
Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update BioSpace
Published: May 18, 2026, 1:17 a.m.
Maipl Therapeutics Advances Non-Hormonal Oral Endometriosis Therapy Targeting Prostaglandin F2α Receptor - Femtech Insider
Maipl Therapeutics Advances Non-Hormonal Oral Endometriosis Therapy Targeting Prostaglandin F2α Receptor Femtech Insider
Published: May 15, 2026, 11:33 a.m.
A review on shared genetic architecture of endometriosis and migraine: from pleiotropy to convergent inflammatory pathways.
The comorbidity between endometriosis and migraine has long been recognized clinically, yet a unifying pathophysiological explanation has remained elusive. Traditional models, centered on hormonal fluctuations or secondary inflammation are lacking …
Published: May 15, 2026, midnight
Karyopharm Therapeutics Reports Q1 2026 Results, Advances Selinexor Phase 3 Trials in Myelofibrosis and Endometrial Cancer - Minichart
Karyopharm Therapeutics Reports Q1 2026 Results, Advances Selinexor Phase 3 Trials in Myelofibrosis and Endometrial Cancer Minichart
Published: May 14, 2026, 4:30 p.m.
Maipl Therapeutics Reports Preclinical Progress for MA-4604, a Novel Oral Non-Hormonal Treatment of Endometriosis - Newswise
Maipl Therapeutics Reports Preclinical Progress for MA-4604, a Novel Oral Non-Hormonal Treatment of Endometriosis Newswise
Published: May 14, 2026, 12:40 p.m.
Link copied to clipboard!